World Medicine Organization
popular searches
medicine
Home
|
/
News
|
/
Conferences
|
/
Regions
|
/
About WMO
Register
Login
Cancer Vaccine IFx-Hu2.0 Confers Immune Priming Effect in Previously Treated MCC and CSCC
IBI322 Shows Early Antitumor Efficacy in PD-1/PD-L1–Resistant Classical Hodgkin Lymphoma
Cancer Vaccine IFx-Hu2.0 Confers Immune Priming Effect in Previously Treated MCC and CSCC
2023-08-17
The novel personalized cancer vaccine IFx-Hu2.0 was found to be safe and well tolerated with weekly dosing in patients with checkpoint inhibitor–resistant cutaneous squamous cell carcinoma (CSCC) a...
IBI322 Shows Early Antitumor Efficacy in PD-1/PD-L1–Resistant Classical Hodgkin Lymphoma
2023-08-17
Single-agent IBI322 elicited responses with favorable safety in patients with classical Hodgkin lymphoma that had become resistant to anti–PD-1/PD-L1 therapy, according to data from a phase 1 trial...
GVAX Cancer Vaccine Plus Nivolumab and Urelumab Elicits Early Efficacy in Pancreatic Adenocarcinoma
2023-08-17
Treatment with the GVAX pancreatic cancer vaccine plus nivolumab (Opdivo) and urelumab increased the presence of intratumoral activated cytotoxic T cells and showed early signs of efficacy in patie...
BAT8006 Elicits Disease Control, Safety in Advanced Ovarian Cancer and Other Solid Tumors
2023-08-17
Treatment with the folate receptor–α (FRα) antibody-drug conjugate BAT8006 led to responses with a manageable safety profile in patients with advanced solid tumors, including ovarian cancer, breast...
Molecular Subtyping and Surgical Sequencing Broaden Immunotherapy Applications in RCC
2023-08-17
Future advances in renal cell carcinoma (RCC) management hinge on better defined molecular selection and treatment sequencing, according to Tian Zhang, MD, who noted that the ongoing phase 2 OPTIC ...
GVAX Cancer Vaccine Plus Nivolumab and Urelumab Elicits Early Efficacy in Pancreatic Adenocarcinoma
Brain Volume Patterns Vary Across Psychiatric Disorders
Conference
Focus
1
Disease and Viruses
1
Rehabilitation
1
Detection & Analysis
1
Drugs and therapy
NK T-Cell Agonist Under Investigation in Combination With Pembrolizumab in Melanoma and NSCLC
2023-08-17
The natural killer T-cell agonist IMM60 may overcome resistance to PD-1 inhibitors when combined with immunotherapy in patients with melanoma and non–small cell lung cancer.Nicholas Coupe, MBBS, Ph...
Dr. Ehrhardt on Factors Associated with Late Mortality in Survivors of Childhood Cancer
2023-08-17
Matthew J. Ehrhardt, MD, MS, discusses the link between modifiable chronic health conditions and social determinants of health with late mortality for survivors of childhood cancer.PauseMuteCurrent...
Brain Volume Patterns Vary Across Psychiatric Disorders
2023-08-17
A large brain imaging study of adults with six different psychiatric illnesses shows that heterogeneity in regional gray matter volume deviations is a general feature of psychiatric illness, but th...
Pig Kidneys Show 'Life-Sustaining' Function in Human
2023-08-17
A pair of genetically modified pig kidneys filtered blood and produced urine for 7 days after being transplanted into a brain-dead patient ― marking another important step toward opening up a new...
World Medicine Organization
©
2023
we@wmo.com
电话咨询:020-000000
QQ咨询:177488228
微信客服
扫码咨询